Zydus Lifesciences share price
You have to be logged in to add this to Watchlist.Zydus Lifesciences is trading -1.40% lower at Rs 1,099.50 as compared to its last closing price. Zydus Lifesciences has been trading in the price range of 1,119.85 & 1,097.70. Zydus Lifesciences has given 61.80% in this year & -1.49% in the last 5 days.
Zydus Lifesciences has TTM P/E ratio 26.00 as compared to the sector P/E of 31.02.There are 26 analysts who have initiated coverage on Zydus Lifesciences. There are 3 analysts who have given it a strong buy rating & 5 analysts have given it a buy rating. 5 analysts have given the stock a sell rating.
The company posted a net profit of 1,419.90 Crores in its last quarter.
Listed peers of Zydus Lifesciences include Cipla (-0.85%), Torrent Pharmaceuticals (-0.72%), Zydus Lifesciences (-1.40%) etc.
Zydus Lifesciences has a 74.98% promoter holding & 25.02% public holding.The Mutual Fund holding in Zydus Lifesciences was at 5.22% in 30 Jun 2024. The MF holding has decreased from the last quarter. The FII holding in Zydus Lifesciences was at 5.59% in 30 Jun 2024. The FII holding has decreased from the last quarter.
Zydus Lifesciences share price range
|
| ||||
|
| ||||
Zydus Lifesciences share Key Metrics
| Market Cap ( ₹ Cr.) | 1,12,210.20 | ||||||||||||||||||
|
|
Technical Trends
Long TermConsiders price movement over the last 6 months
Short TermConsiders price movement over the last 1-2 weeks
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Zydus Lifesciences Corporate actions
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
| 09-Aug-24 | Quarterly Results |
| 17-May-24 | Audited Results & Final Dividend |
| 09-Feb-24 | Quarterly Results & Buy Back of shares |
| 07-Nov-23 | Quarterly Results |
| 11-Aug-23 | Quarterly Results |
| 18-May-23 | Audited Results & Final Dividend |
| 03-Feb-23 | Quarterly Results |
| 11-Nov-22 | Quarterly Results |
| 10-Aug-22 | Quarterly Results |
| 20-May-22 | Audited Results, Dividend & Buy Back |
| Meeting Date | Announcement On | Purpose |
| 11-Aug-23 | 18-May-23 | AGM |
| 10-Aug-22 | 21-May-22 | AGM |
| 18-Feb-22 | 25-Jan-22 | EGM |
| 11-Aug-21 | 27-May-21 | AGM |
| 11-Jun-21 | 18-May-21 | EGM |
| - | 20-May-22 | Others |
| - | 12-Feb-24 | Others |
| Announcement On | Record Date | Ex-Dividend | Dividend Value |
| 17-May-24 | 26-Jul-24 | 26-Jul-24 | 3 |
| 18-May-23 | 28-Jul-23 | 28-Jul-23 | 6 |
| 20-May-22 | 29-Jul-22 | 28-Jul-22 | 2.5 |
| 27-May-21 | - | 28-Jul-21 | 3.5 |
FAQs about Zydus Lifesciences share price
Zydus Lifesciences is trading at 1099.50 as on Fri Sep 06 2024 09:59:59. This is -1.40% lower as compared to its previous closing price of 1115.10.
The market capitalization of Zydus Lifesciences is 110635.43 Cr as on Fri Sep 06 2024 09:59:59.
The average broker rating on Zydus Lifesciences is Hold. The breakup of analyst rating is given below -
- 3 analysts have given a strong buy rating
- 5 analysts have given a buy rating
- 10 analysts have given a hold rating
- 5 analysts have given a sell rating
- 3 analysts have given a strong sell rating
The 52 wk high for Zydus Lifesciences is 1323.90 whereas the 52 wk low is 567.85
Zydus Lifesciences can be analyzed on the following key metrics -
- TTM P/E: 26.00
- Sector P/E: 31.02
- Dividend Yield: 0.27%
- D/E ratio: -
Zydus Lifesciences reported a net profit of 3859.50 Cr in 2024.
Zydus Lifesciences Quick Links
Zydus Lifesciences Dividend Zydus Lifesciences Bonus Zydus Lifesciences News Zydus Lifesciences AGM Zydus Lifesciences Rights Zydus Lifesciences Splits Zydus Lifesciences Board Meetings Zydus Lifesciences Key Metrics Zydus Lifesciences Shareholdings Zydus Lifesciences Profit Loss Zydus Lifesciences Balance Sheet Zydus Lifesciences Cashflow Zydus Lifesciences Q1 Results Zydus Lifesciences Q2 Results Zydus Lifesciences Q3 Results Zydus Lifesciences Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks